184 related articles for article (PubMed ID: 21286028)
1. Incontinentia pigmenti in a newborn with NEMO mutation.
Lee Y; Kim S; Kim K; Chang M
J Korean Med Sci; 2011 Feb; 26(2):308-11. PubMed ID: 21286028
[TBL] [Abstract][Full Text] [Related]
2. The common NF-κB essential modulator (NEMO) gene rearrangement in Korean patients with incontinentia pigmenti.
Song MJ; Chae JH; Park EA; Ki CS
J Korean Med Sci; 2010 Oct; 25(10):1513-7. PubMed ID: 20890435
[TBL] [Abstract][Full Text] [Related]
3. NEMO gene mutations in Chinese patients with incontinentia pigmenti.
Hsiao PF; Lin SP; Chiang SS; Wu YH; Chen HC; Lin YC
J Formos Med Assoc; 2010 Mar; 109(3):192-200. PubMed ID: 20434027
[TBL] [Abstract][Full Text] [Related]
4. Immunodeficiency in Two Female Patients with Incontinentia Pigmenti with Heterozygous NEMO Mutation Diagnosed by LPS Unresponsiveness.
Ohnishi H; Kishimoto Y; Taguchi T; Kawamoto N; Nakama M; Kawai T; Nakayama M; Ohara O; Orii K; Fukao T
J Clin Immunol; 2017 Aug; 37(6):529-538. PubMed ID: 28702714
[TBL] [Abstract][Full Text] [Related]
5. NEMO gene rearrangement (exon 4-10 deletion) and genotype-phenotype relationship in Japanese patients with incontinentia pigmenti and review of published work in Japanese patients.
Okita M; Nakanishi G; Fujimoto N; Shiomi M; Yamada T; Wataya-Kaneda M; Takijiri C; Yokoyama Y; Sunohara A; Tanaka T
J Dermatol; 2013 Apr; 40(4):272-6. PubMed ID: 23398170
[TBL] [Abstract][Full Text] [Related]
6. Lack of interaction between NEMO and SHARPIN impairs linear ubiquitination and NF-κB activation and leads to incontinentia pigmenti.
Bal E; Laplantine E; Hamel Y; Dubosclard V; Boisson B; Pescatore A; Picard C; Hadj-Rabia S; Royer G; Steffann J; Bonnefont JP; Ursini VM; Vabres P; Munnich A; Casanova JL; Bodemer C; Weil R; Agou F; Smahi A
J Allergy Clin Immunol; 2017 Dec; 140(6):1671-1682.e2. PubMed ID: 28249776
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular analysis of NF-kappaB essential modulator in Chinese incontinentia pigmenti patients.
Zou CC; Zhao ZY
Int J Dermatol; 2007 Oct; 46(10):1017-22. PubMed ID: 17910706
[TBL] [Abstract][Full Text] [Related]
8. [Incontinentia pigmenti (Bloch-Sulzberger syndrome)].
Mühlenstädt E; Eigelshoven S; Hoff NP; Reifenberger J; Homey B; Bruch-Gerharz D
Hautarzt; 2010 Oct; 61(10):831-3. PubMed ID: 20865235
[TBL] [Abstract][Full Text] [Related]
9. De novo NEMO gene deletion (delta4-10)--a cause of incontinentia pigmenti in a female infant: a case report.
Culić V; Gabrić D; Puizina-Ivić N; Rozman K; Peterlin B; Pavelić J
Coll Antropol; 2008 Dec; 32(4):1259-62. PubMed ID: 19149237
[TBL] [Abstract][Full Text] [Related]
10. Serial cytokine expressions in infants with incontinentia pigmenti.
Liao SL; Lai SH; Huang JL; Lee NC; Lee WI
Immunobiology; 2013 May; 218(5):772-9. PubMed ID: 23079196
[TBL] [Abstract][Full Text] [Related]
11. Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease.
Conte MI; Pescatore A; Paciolla M; Esposito E; Miano MG; Lioi MB; McAleer MA; Giardino G; Pignata C; Irvine AD; Scheuerle AE; Royer G; Hadj-Rabia S; Bodemer C; Bonnefont JP; Munnich A; Smahi A; Steffann J; Fusco F; Ursini MV
Hum Mutat; 2014 Feb; 35(2):165-77. PubMed ID: 24339369
[TBL] [Abstract][Full Text] [Related]
12. Incontinentia pigmenti with NEMO mutation in a Japanese family.
Okita M; Nakanishi G; Fujimoto N; Kishida M; Tanaka T
J Dermatol; 2012 Nov; 39(11):940-1. PubMed ID: 22300264
[No Abstract] [Full Text] [Related]
13. Incontinentia pigmenti (Bloch-Sulzberger syndrome).
Narayanan MJ; Rangasamy S; Narayanan V
Handb Clin Neurol; 2015; 132():271-80. PubMed ID: 26564087
[TBL] [Abstract][Full Text] [Related]
14. A genetic cause for neonatal encephalopathy: incontinentia pigmenti with NEMO mutation.
Loh NR; Jadresic LP; Whitelaw A
Acta Paediatr; 2008 Mar; 97(3):379-81. PubMed ID: 18241293
[TBL] [Abstract][Full Text] [Related]
15. Incontinentia pigmenti in a Japanese female infant with a novel frame-shift mutation in the IKBKG gene.
Li M; Higashi N; Nakano H; Saeki H
J Dermatol; 2019 Jan; 46(1):e26-e28. PubMed ID: 29923632
[No Abstract] [Full Text] [Related]
16. [NEMO Delta 4-10 deletion of NEMO gene in Chinese incontinentia pigmenti cases].
Li L; Song GW; DU JB; Liu JR; Xu FS; Liu XY; Zhang T
Zhonghua Er Ke Za Zhi; 2005 Feb; 43(2):89-92. PubMed ID: 15833158
[TBL] [Abstract][Full Text] [Related]
17. Genomic architecture at the Incontinentia Pigmenti locus favours de novo pathological alleles through different mechanisms.
Fusco F; Paciolla M; Napolitano F; Pescatore A; D'Addario I; Bal E; Lioi MB; Smahi A; Miano MG; Ursini MV
Hum Mol Genet; 2012 Mar; 21(6):1260-71. PubMed ID: 22121116
[TBL] [Abstract][Full Text] [Related]
18. Incontinentia pigmenti in a male (XY) infant with long-term follow up over 8 years.
Matsuzaki Y; Rokunohe A; Minakawa S; Nomura K; Nakano H; Ito E; Sawamura D
J Dermatol; 2018 Jan; 45(1):100-103. PubMed ID: 28791733
[TBL] [Abstract][Full Text] [Related]
19. De Novo incontinentia pigmenti in female twins.
Su PH; Chen JY; Yu JS; Su CM; Huang TC; Chen SJ
Acta Paediatr Taiwan; 2004; 45(3):178-80. PubMed ID: 15493740
[TBL] [Abstract][Full Text] [Related]
20. [From gene to disease; incontinentia pigmenti and the NEMO-gene].
Oranje AP; Arts WF; Wagner A; van der Hout AH; Simonsz HJ
Ned Tijdschr Geneeskd; 2005 Jul; 149(30):1682-5. PubMed ID: 16104114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
